We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Patent Protects DNA Display Technology

By Biotechdaily staff writers
Posted on 02 Aug 2004
A European patent has been granted to protect technology designed to display and identify individual clones from antibody and peptide libraries.

The patent was granted to Haptogen Ltd. More...
(Aberdeen, UK) for its DBDxT display technology. The patent protects the usage of this technology for display of proteins including antibody binding sites, the maintenance of large repertoires of different proteins, and the selection from these repertoires of specific therapeutic drug leads.

DBDxT has already been used in conjunction with Haptogen's Haptomics protocol to develop antibodies against specific signaling molecules produced by both Gram-positive and Gram-negative bacteria. Since these antibodies are not directed against the bacteria, it is felt that they will not drive the bacteria into developing resistance against them.

Dr. Jim Reid, CEO of Haptogen, said, "Using DBDx technology in combination with our unique HaptomicsT protocols and antibody libraries, we have developed a bio-selection process that we term FEST or Forced Epitope Selection. This facilitates the isolation of highly specific antibodies to targets usually considered beyond the scope of current immuno-technologies.”




Related Links:
Haptogen Ltd.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
All-in-One Molecular System
AIO M160
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Simple Whole-Blood Screen Identifies Elevated Bile Acids Linked to Liver Disease

Liver disease can progress silently until treatment options become more limited. Routine blood panels measure markers such as cholesterol, bilirubin, and triglycerides but typically do not include bile... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.